163 related articles for article (PubMed ID: 16537196)
21. Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid.
McPherson S; Perrier J; Dunn C; Khadra I; Davidson S; Ainousah B; Wilson CG; Halbert G
Eur J Pharm Biopharm; 2020 May; 150():14-23. PubMed ID: 32035969
[TBL] [Abstract][Full Text] [Related]
22. Permeapad™ for investigation of passive drug permeability: The effect of surfactants, co-solvents and simulated intestinal fluids (FaSSIF and FeSSIF).
Bibi HA; di Cagno M; Holm R; Bauer-Brandl A
Int J Pharm; 2015 Sep; 493(1-2):192-7. PubMed ID: 26192628
[TBL] [Abstract][Full Text] [Related]
23. Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents.
Kalantzi L; Persson E; Polentarutti B; Abrahamsson B; Goumas K; Dressman JB; Reppas C
Pharm Res; 2006 Jun; 23(6):1373-81. PubMed ID: 16715357
[TBL] [Abstract][Full Text] [Related]
24. Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.
Dahlgren D; Venczel M; Ridoux JP; Skjöld C; Müllertz A; Holm R; Augustijns P; Hellström PM; Lennernäs H
Eur J Pharm Biopharm; 2021 Jun; 163():240-251. PubMed ID: 33872761
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification.
Incecayir T; Tsume Y; Amidon GL
Mol Pharm; 2013 Mar; 10(3):958-66. PubMed ID: 23327720
[TBL] [Abstract][Full Text] [Related]
26. Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2.
Collett A; Higgs NB; Sims E; Rowland M; Warhurst G
J Pharmacol Exp Ther; 1999 Jan; 288(1):171-8. PubMed ID: 9862768
[TBL] [Abstract][Full Text] [Related]
27. Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media.
Fagerberg JH; Tsinman O; Sun N; Tsinman K; Avdeef A; Bergström CA
Mol Pharm; 2010 Oct; 7(5):1419-30. PubMed ID: 20507160
[TBL] [Abstract][Full Text] [Related]
28. Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium.
Kamei N; Aoyama Y; Khafagy el-S; Henmi M; Takeda-Morishita M
Eur J Pharm Biopharm; 2015 Aug; 94():42-51. PubMed ID: 25960330
[TBL] [Abstract][Full Text] [Related]
29. Fasted-state simulated intestinal fluid "FaSSIF-C", a cholesterol containing intestinal model medium for in vitro drug delivery development.
Khoshakhlagh P; Johnson R; Langguth P; Nawroth T; Schmueser L; Hellmann N; Decker H; Szekely NK
J Pharm Sci; 2015 Jul; 104(7):2213-24. PubMed ID: 25964103
[TBL] [Abstract][Full Text] [Related]
30. A systematic examination of the in vitro Ussing chamber and the in situ single-pass perfusion model systems in rat ileum permeation of model solutes.
Tsutsumi K; Li SK; Ghanem AH; Ho NF; Higuchi WI
J Pharm Sci; 2003 Feb; 92(2):344-59. PubMed ID: 12532384
[TBL] [Abstract][Full Text] [Related]
31. Oligonucleotide transport in rat and human intestine ussing chamber models.
Wu-Pong S; Livesay V; Dvorchik B; Barr WH
Biopharm Drug Dispos; 1999 Dec; 20(9):411-6. PubMed ID: 10951429
[TBL] [Abstract][Full Text] [Related]
32. Simulating fasted human intestinal fluids: understanding the roles of lecithin and bile acids.
Söderlind E; Karlsson E; Carlsson A; Kong R; Lenz A; Lindborg S; Sheng JJ
Mol Pharm; 2010 Oct; 7(5):1498-507. PubMed ID: 20698569
[TBL] [Abstract][Full Text] [Related]
33. Biorelevant refinement of the Caco-2 cell culture model to assess efficacy of paracellular permeability enhancers.
Tippin TK; Thakker DR
J Pharm Sci; 2008 May; 97(5):1977-92. PubMed ID: 17724658
[TBL] [Abstract][Full Text] [Related]
34. Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids.
Clarysse S; Brouwers J; Tack J; Annaert P; Augustijns P
Eur J Pharm Sci; 2011 Jul; 43(4):260-9. PubMed ID: 21570465
[TBL] [Abstract][Full Text] [Related]
35. Influence of monocaprin on the permeability of a diacidic drug BTA-243 across Caco-2 cell monolayers and everted gut sacs.
Brown JR; Collett JH; Attwood D; Ley RW; Sims EE
Int J Pharm; 2002 Oct; 245(1-2):133-42. PubMed ID: 12270250
[TBL] [Abstract][Full Text] [Related]
36. Regional permeability of salmon calcitonin in isolated rat gastrointestinal tracts: transport mechanism using Caco-2 cell monolayer.
Shah RB; Khan MA
AAPS J; 2004 Oct; 6(4):e31. PubMed ID: 15760096
[TBL] [Abstract][Full Text] [Related]
37. Melittin as a permeability enhancer II: in vitro investigations in human mucus secreting intestinal monolayers and rat colonic mucosae.
Maher S; Feighery L; Brayden DJ; McClean S
Pharm Res; 2007 Jul; 24(7):1346-56. PubMed ID: 17380268
[TBL] [Abstract][Full Text] [Related]
38. The Evaluation of In Vitro Drug Dissolution of Commercially Available Oral Dosage Forms for Itraconazole in Gastrointestinal Simulator With Biorelevant Media.
Matsui K; Tsume Y; Amidon GE; Amidon GL
J Pharm Sci; 2016 Sep; 105(9):2804-2814. PubMed ID: 27020985
[TBL] [Abstract][Full Text] [Related]
39. Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs.
Fossati L; Dechaume R; Hardillier E; Chevillon D; Prevost C; Bolze S; Maubon N
Int J Pharm; 2008 Aug; 360(1-2):148-55. PubMed ID: 18539418
[TBL] [Abstract][Full Text] [Related]
40. Comparison of HT29-18-C1 and Caco-2 cell lines as models for studying intestinal paracellular drug absorption.
Collett A; Sims E; Walker D; He YL; Ayrton J; Rowland M; Warhurst G
Pharm Res; 1996 Feb; 13(2):216-21. PubMed ID: 8932439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
